Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026)
Elanco Animal Health (ELAN) posted Accounts Payables of $372.0 million for Q1 2026, up 1.09% sequentially from $368.0 million in Q4 2025, and up 12.73% YoY from $330.0 million in Q1 2025.
Elanco Animal Health (ELAN) Accounts Payables (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Accounts Payables for 10 years, with the latest figure at $372.0 million in Q1 2026.
- Quarterly Accounts Payables rose 12.73% year-over-year to $372.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $372.0 million (up 12.73% YoY) and the FY2025 annual result came in at $368.0 million, up 24.32% from the prior year.
- Accounts Payables climbed to $372.0 million in Q1 2026 per ELAN's latest filing, from $368.0 million in the prior quarter.
- Over five years, Accounts Payables peaked at $402.0 million in Q1 2022 and troughed at $259.0 million in Q3 2024.
- A 5-year average of $339.2 million and a median of $352.0 million in 2025 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables sank 30.77% in 2023, then soared 35.91% in 2025.
- Over 5 years, Accounts Payables stood at $390.0 million in 2022, then tumbled by 30.77% to $270.0 million in 2023, then rose by 9.63% to $296.0 million in 2024, then increased by 24.32% to $368.0 million in 2025, then rose by 1.09% to $372.0 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $372.0 million, $368.0 million, and $352.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 332.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 427.00 Mn |
| Mar 31, 2026 | 372.00 Mn |
| Dec 31, 2025 | 368.00 Mn |
| Sep 30, 2025 | 352.00 Mn |
| Jun 30, 2025 | 368.00 Mn |
| Mar 31, 2025 | 330.00 Mn |
| Dec 31, 2024 | 296.00 Mn |
| Sep 30, 2024 | 259.00 Mn |
| Jun 30, 2024 | 291.00 Mn |
| Mar 31, 2024 | 302.00 Mn |
| Dec 31, 2023 | 270.00 Mn |
| Sep 30, 2023 | 296.00 Mn |
| Jun 30, 2023 | 354.00 Mn |
| Mar 31, 2023 | 381.00 Mn |
| Dec 31, 2022 | 390.00 Mn |
| Sep 30, 2022 | 350.00 Mn |
| Jun 30, 2022 | 386.00 Mn |
| Mar 31, 2022 | 402.00 Mn |
| Dec 31, 2021 | 416.00 Mn |
| Sep 30, 2021 | 436.00 Mn |